Metabolic syndrome (MetS) forms a cluster of metabolic dysregulations including insulin
resistance, atherogenic dyslipidemia, central obesity, and hypertension. The pathogenesis …

The definition of metabolic syndrome (MetS) has undergone several changes over the years
due to the difficulty in establishing universal criteria for it. Underlying the disorders related to …

Polyphenols (PPs) are a large group of phytochemicals containing phenolic rings with two or
more hydroxyl groups. They possess powerful antioxidant properties, multiple therapeutic …

Background The presence of metabolic syndrome among diabetes patients is frequent and
is associated with an increased incidence of chronic complications and mortality. Despite …

Endocrine-disrupting chemicals (EDCs) are exogenous compounds that have been known
for their ability to interfere with the action of hormones and affect endocrine pathways …

Glucagon-like peptide-1 (GLP-1) is a human incretin hormone derived from the proglucagon
molecule. GLP-1 receptor agonists are frequently used to treat type 2 diabetes mellitus and …

Metabolic syndrome (MetS) is a constellation of metabolic derangements, including central
obesity, insulin resistance, hypertension, glucose intolerance, and dyslipidemia. The …

Hypertension poses a significant burden in the general population, being responsible for
increasing cardiovascular morbidity and mortality, leading to adverse outcomes. Moreover …

Studies on the impact of Ramadan diurnal intermittent fasting (RDIF) on the metabolic
syndrome (MetS) components among healthy Muslims observing Ramadan month have …

Apart from well-known functions of bile acids in digestion and solubilization of lipophilic
nutrients and drugs in the small intestine, the emerging evidence from the past two decades …